HYPMY
Price
$5.02
Change
+$0.19 (+3.93%)
Updated
Jul 2 closing price
Capitalization
5.79B
KMDA
Price
$7.88
Change
+$0.14 (+1.81%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
306.49M
40 days until earnings call
Interact to see
Advertisement

HYPMY vs KMDA

Header iconHYPMY vs KMDA Comparison
Open Charts HYPMY vs KMDABanner chart's image
Hypera SA
Price$5.02
Change+$0.19 (+3.93%)
Volume$944
Capitalization5.79B
Kamada
Price$7.88
Change+$0.14 (+1.81%)
Volume$100
Capitalization306.49M
HYPMY vs KMDA Comparison Chart in %
Loading...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYPMY vs. KMDA commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPMY is a Hold and KMDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (HYPMY: $5.03 vs. KMDA: $7.88)
Brand notoriety: HYPMY and KMDA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HYPMY: 3118% vs. KMDA: 31%
Market capitalization -- HYPMY: $5.79B vs. KMDA: $306.49M
HYPMY [@Pharmaceuticals: Other] is valued at $5.79B. KMDA’s [@Pharmaceuticals: Other] market capitalization is $306.49M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPMY’s FA Score shows that 2 FA rating(s) are green whileKMDA’s FA Score has 1 green FA rating(s).

  • HYPMY’s FA Score: 2 green, 3 red.
  • KMDA’s FA Score: 1 green, 4 red.
According to our system of comparison, HYPMY is a better buy in the long-term than KMDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPMY’s TA Score shows that 3 TA indicator(s) are bullish while KMDA’s TA Score has 4 bullish TA indicator(s).

  • HYPMY’s TA Score: 3 bullish, 4 bearish.
  • KMDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KMDA is a better buy in the short-term than HYPMY.

Price Growth

HYPMY (@Pharmaceuticals: Other) experienced а +9.26% price change this week, while KMDA (@Pharmaceuticals: Other) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

HYPMY is expected to report earnings on Apr 23, 2025.

KMDA is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPMY($5.79B) has a higher market cap than KMDA($306M). KMDA has higher P/E ratio than HYPMY: KMDA (37.43) vs HYPMY (15.95). HYPMY YTD gains are higher at: 71.085 vs. KMDA (33.100). HYPMY has higher annual earnings (EBITDA): 2.86B vs. KMDA (22.4M). HYPMY has higher revenues than KMDA: HYPMY (7.75B) vs KMDA (143M).
HYPMYKMDAHYPMY / KMDA
Capitalization5.79B306M1,892%
EBITDA2.86B22.4M12,750%
Gain YTD71.08533.100215%
P/E Ratio15.9537.4343%
Revenue7.75B143M5,420%
Total CashN/A55.6M-
Total DebtN/A8.82M-
FUNDAMENTALS RATINGS
HYPMY vs KMDA: Fundamental Ratings
HYPMY
KMDA
OUTLOOK RATING
1..100
519
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
7980
PRICE GROWTH RATING
1..100
3941
P/E GROWTH RATING
1..100
1027
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPMY's Valuation (15) in the null industry is somewhat better than the same rating for KMDA (73) in the Biotechnology industry. This means that HYPMY’s stock grew somewhat faster than KMDA’s over the last 12 months.

KMDA's Profit vs Risk Rating (98) in the Biotechnology industry is in the same range as HYPMY (100) in the null industry. This means that KMDA’s stock grew similarly to HYPMY’s over the last 12 months.

HYPMY's SMR Rating (79) in the null industry is in the same range as KMDA (80) in the Biotechnology industry. This means that HYPMY’s stock grew similarly to KMDA’s over the last 12 months.

HYPMY's Price Growth Rating (39) in the null industry is in the same range as KMDA (41) in the Biotechnology industry. This means that HYPMY’s stock grew similarly to KMDA’s over the last 12 months.

HYPMY's P/E Growth Rating (10) in the null industry is in the same range as KMDA (27) in the Biotechnology industry. This means that HYPMY’s stock grew similarly to KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HYPMYKMDA
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
66%
Declines
ODDS (%)
N/A
Bearish Trend 21 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEGRY17.180.32
+1.90%
Weir Group PLC
CIIHY30.100.23
+0.77%
Citic Securities Co., Ltd.
FDVA11.26N/A
N/A
FREEDOM FINL HLDGS INC.
WELX4.70N/A
N/A
Winland Holdings Corporation
HTWSF1.63N/A
N/A
Helios Towers PLC.

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and AYRWF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and AYRWF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
+0.12%
AYRWF - HYPMY
23%
Poorly correlated
-4.96%
PLNH - HYPMY
21%
Poorly correlated
+6.02%
CPIX - HYPMY
20%
Poorly correlated
-7.62%
GLASF - HYPMY
20%
Poorly correlated
+2.88%
KMDA - HYPMY
20%
Poorly correlated
+1.81%
More